Singapore markets close in 2 hours 59 minutes
Straits Times Index
3,292.48 -0.21 (-0.01%) Nikkei
38,246.02 -28.03 (-0.07%) Hang Seng
18,194.68 +431.65 (+2.43%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,447.20 -2,498.80 (-4.17%) CMC Crypto 200
1,257.30 -13.44 (-1.06%)
ABT Jan 2025 105.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:02PM EDT. Market open.
| Previous close | 9.85 |
| Open | 9.85 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 105.00 |
| Expiry date | 2025-01-17 |
| Day's range | 9.85 - 9.85 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.